3-iodobenzylguanidine has been researched along with thyroxine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
George, P; Henderson, BL; Karvounaris, D; Lavender, JP; Lynn, JA; Macdonald, DW; Poston, GJ; Thomas, AM | 1 |
Ferraironi, A; Festa, A; Maini, CL; Rea, S; Sciuto, R; Tofani, A | 1 |
de Kraker, J; de Vijlder, JJ; van Eck, BL; van Santen, HM; Vulsma, T | 2 |
4 other study(ies) available for 3-iodobenzylguanidine and thyroxine
Article | Year |
---|---|
Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
Topics: 3-Iodobenzylguanidine; Adult; Calcitonin; Carcinoma; Epinephrine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Neoplasm Metastasis; Norepinephrine; Radionuclide Imaging; Thyroid Neoplasms; Thyroidectomy; Thyroxine | 1986 |
Myocardial 123I-MIBG kinetics in acutely hypothyroid patients with differentiated thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Heart; Humans; Hypothyroidism; Kinetics; Male; Middle Aged; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroxine; Triiodothyronine | 1999 |
High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasm Staging; Neuroblastoma; Potassium Iodide; Premedication; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Thyroid Diseases; Thyroid Gland; Thyrotropin; Thyroxine | 2002 |
Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Methimazole; Neuroblastoma; Potassium Iodide; Radiation-Protective Agents; Thyroid Diseases; Thyroid Function Tests; Thyroxine; Treatment Outcome | 2003 |